Related Experiment Video
Updated: May 22, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Spontaneous resolution of extreme thrombocytosis in 2 children
Shraga Aviner1, Ehud Even-Or, Hannah Tamary
1Department of Pediatrics, Barzilai Medical Center, Ashkelon, Israel. aviners@barzi.health.gov.il
Insights
Essential thrombocytosis (ET) in children is challenging to differentiate from secondary causes. Two pediatric cases with extreme thrombocytosis showed spontaneous remission, suggesting secondary causes and the need for careful treatment decisions.
Area of Science:
- Pediatric Hematology
- Oncology
- Internal Medicine
Background:
- Essential thrombocytosis (ET) is a rare myeloproliferative neoplasm in children.
- Distinguishing ET from secondary thrombocytosis can be diagnostically challenging.
- Extreme thrombocytosis necessitates careful evaluation of underlying causes.
Abstract:
Essential thrombocytosis (ET) is rare in children, sometimes difficult to be distinguished from secondary thrombocytosis. This report concerns 2 children with extreme thrombocytosis of 4100 × 10(9)/L and 1644 × 10(9)/L with partial and complete remission at 3 months and 4 years from diagnosis, with a follow-up of 4 and 17 years, respectively, with no cytoreduction therapy. Diagnosis of ET was suggested according to accepted criteria. However, spontaneous remission of the thrombocytosis argues for the diagnosis of secondary thrombocytosis. These patients highlight the complexity of distinguishing childhood ET from secondary thrombocytosis and the need for cautious personalized decision on cytoreduction therapy.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...